OESOPHAGECTOMY FOR OESOPHAGEAL CANCER:
THE PROCEDURE AND RECOVERY
Oesophagectomy is one of surgery's most demanding operations β and the only curative option for resectable oesophageal cancer. Knowing what lies ahead allows patients and families to prepare meaningfully.
analyticsAt a Glance
- check_circleFLOT or carboplatin/paclitaxel + RT standard before surgery for most resectable cases
- check_circleHospital stay 10β14 days; full recovery 8β12 weeks
- check_circleMinimally invasive oesophagectomy (MIO) reduces pulmonary complications significantly
- check_circleHigh-volume oesophageal cancer centres in India offer oesophagectomy at 60β70% lower cost than the USA
Neoadjuvant Therapy Before Oesophagectomy: The New Standard
For most patients with resectable oesophageal or gastro-oesophageal junction cancer, surgery is no longer the first step β neoadjuvant therapy is given first to downstage the tumour and improve R0 resection rates.
FLOT Chemotherapy (Adenocarcinoma)
Four cycles of FLOT (5-fluorouracil, leucovorin, oxaliplatin, docetaxel) before and after surgery is standard for resectable oesophageal/GOJ adenocarcinoma (FLOT4 trial β improved OS vs ECF). Achieves pathological complete response (pCR) in 16% and R0 resection in 84% of patients.
Carboplatin/Paclitaxel + RT (Squamous Cell / Adenocarcinoma)
The CROSS protocol (carboplatin + paclitaxel + concurrent RT 41.4 Gy) followed by surgery is standard for both squamous cell and adenocarcinoma in many centres (CROSS trial β improved OS, pCR 29% for SCC, 23% for adenocarcinoma).
Oesophagectomy Approaches: Ivor Lewis, McKeown, and MIO
Surgical approach is determined by tumour location, planned anastomosis site, and surgeon preference and training.
| Approach | Access | Anastomosis | Best For |
|---|---|---|---|
| Ivor Lewis (two-stage) | Abdominal phase + right thoracotomy | Intrathoracic (right chest) | Mid-thoracic and lower third oesophageal tumours; most common approach globally |
| McKeown (three-stage) | Abdominal + right thoracic + left neck | Cervical anastomosis | Upper third oesophagus; cervical anastomosis preferred to avoid intrathoracic leak |
| Transhiatal (TH) | Abdominal + left neck (no thoracotomy) | Cervical anastomosis | Avoids thoracotomy β useful in poor pulmonary reserve; limited thoracic lymphadenectomy |
| Minimally invasive (MIO) | Thoracoscopic + laparoscopic | Intrathoracic or cervical depending on variant | Centres with MIS expertise; reduces pulmonary complications vs open (TIME trial) |
| Hybrid MIO | Laparoscopic abdomen + open thorax (or vice versa) | Intrathoracic or cervical | Transition to full MIO; many centres; reduces abdominal wound complications |
Recovery After Oesophagectomy: Phase by Phase
Oesophagectomy recovery is gradual and multi-phased β pulmonary care, nutritional rehabilitation, and anastomosis healing are the three parallel recovery processes.
- 1
Days 1β3: ICU β Pulmonary Care Priority
Extubation usually at end of operation or within 24 hours. Chest physiotherapy, early mobilisation, and incentive spirometry begin immediately. Epidural or thoracic paravertebral block provides pain control. Chest drains manage pleural fluid. The gastric conduit starts draining bile and secretions via NGT.
- 2
Days 4β7: Swallow Assessment
Contrast swallow study at day 5β7 to confirm anastomosis integrity before oral intake begins. If no leak: sips of water introduced; clear fluids advanced; soft purΓ©ed diet by day 7β8. If anastomotic leak confirmed: nil by mouth; intervention (endoscopic stenting, drainage, or conservative management).
- 3
Discharge (Day 10β14)
Hospital stay is 10β14 days (open); 8β12 days (MIO). Discharge requires: adequate oral nutrition intake, drains removed, pain controlled on oral analgesia, chest physiotherapy independence. Patients are discharged on a specific oesophagectomy diet β small frequent meals, avoiding lying flat for 90 minutes after eating, anti-reflux positioning.
- 4
Weeks 4β12: Nutritional Rehabilitation
Patients lose 5β10% body weight during neoadjuvant therapy and surgery. Nutritional recovery requires 6β12 weeks of structured dietitian-guided rehabilitation. Dumping syndrome (early: dizziness, palpitations after eating) affects 20β30%; managed with small meals, low-sugar diet. Weight often stabilises at 6 months.
- 5
Adjuvant Therapy and Follow-Up
FLOT patients: 4 cycles of adjuvant FLOT after recovery (cycle 5β8 of peri-operative protocol). CROSS patients: if ypN+ on final pathology, adjuvant nivolumab (CheckMate 577 trial) is standard for SCC and adenocarcinoma after R0 resection following CRT. CT restaging at 3, 6, 12 months.
Key Complications to Know About
Oesophagectomy has a significant complication profile β understanding what to watch for helps patients and carers seek timely medical attention.
Anastomotic Leak (5β15%)
The most feared complication β occurring at the join between the oesophagus/gastric conduit. Symptoms: fever, tachycardia, chest pain, pain on swallowing. Diagnosed on contrast swallow or CT. Management: endoscopic stenting (most cases); surgical drainage for free perforation. Cervical anastomotic leaks are generally less severe than intrathoracic leaks.
Pulmonary Complications (20β30%)
Pneumonia, atelectasis, and respiratory failure are the most common major complications β the primary driver of ICU stay and 30-day mortality. Minimally invasive oesophagectomy significantly reduces pulmonary complications (TIME trial: 9% vs 29% for pneumonia). Pre-operative prehabilitation and post-operative chest physiotherapy are the most effective preventive interventions.
Oesophagectomy Outcomes at High-Volume Centres
- <3%30-Day Mortality β High-Volume Centresvs 8β15% at low-volume centres β volumeβoutcome relationship among strongest in all surgery
- 40β50%5-Year OS After R0 Resection + Perioperative ChemoFor resectable oesophageal/GOJ cancer with pCR or ypN0 pathology
- 9% vs 29%Pneumonia Rate β MIO vs Open (TIME Trial)Minimally invasive oesophagectomy delivers a 3-fold reduction in post-operative pneumonia
- 5β15%Anastomotic Leak RateVaries by centre volume and anastomosis technique; most managed non-operatively with stenting
Related Cancer Surgery Resources
More guides on major cancer surgery and preparation.
Frequently Asked Questions
Oesophagectomy
Will I be able to eat normally after oesophagectomy?
Diet is permanently changed after oesophagectomy β but most patients achieve a satisfying, nutritious eating pattern. The gastric conduit is smaller than the original stomach; early satiety is universal. Patients are advised to eat 5β8 small meals per day rather than 3 large ones, avoid eating within 90 minutes of lying flat, and sleep with the head elevated 30β45Β°. Dumping syndrome (early: sweating, palpitations, diarrhoea after sugary meals) affects 20β30% and is managed with dietary modification. Most patients stabilise their weight and eating pattern by 6β12 months.
Is oesophagectomy available in India and is it safe?
Yes. Major Indian cancer centres β Tata Memorial Hospital, Apollo Hospitals, and AIIMS Delhi β have dedicated oesophageal cancer programmes performing open and minimally invasive oesophagectomy with published outcomes data. The 30-day mortality at high-volume Indian centres is comparable to international benchmarks (<3%). Costs are significantly lower: full oesophagectomy including surgery, ICU stay, and hospital admission costs $6,000β$12,000 in India vs $30,000β$70,000 in the USA. CancerFax can identify the most experienced oesophageal surgeon for your specific tumour type and location.
Why is the volumeβoutcome relationship so important for oesophagectomy?
Oesophagectomy 30-day mortality ranges from <3% at high-volume specialist centres to 8β15% at low-volume centres β one of the strongest volumeβoutcome relationships in all of surgery. This difference reflects not just surgical technical skill but the entire perioperative infrastructure: experienced anaesthetists, ICU teams familiar with post-oesophagectomy physiology, chest physiotherapists, specialist stoma and nutrition nurses, and endoscopy teams capable of managing anastomotic leaks. Selecting a high-volume centre for oesophagectomy is one of the most important decisions a patient can make.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Facing Oesophagectomy? Get a Second Opinion from a High-Volume Centre.
Upload your CT, endoscopy, biopsy, and pathology. CancerFax will review resectability and connect you with experienced oesophageal cancer surgeons in India or China.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.